Market Overview:
The global anemia therapeutics market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of anemia, rising geriatric population, and growing demand for novel therapies. Based on type, the global anemia therapeutics market is segmented into iron deficiency anemia, sickle cell anemia, pernicious anemia, and hemolytic anemia. Iron deficiency anaemias are estimated to account for the largest share of the global market in 2018. This can be attributed to factors such as high incidence rates and easy diagnosis methods for this type of anaemias. Based on application, hospitals are estimated to account for the largest share of the global market in 2018 owing to increased awareness about early diagnosis and treatment options among patients visiting hospitals.
Product Definition:
Anemia Therapeutics is the branch of medicine that deals with the treatment of anemia. Anemia is a condition in which there are low levels of red blood cells or hemoglobin in the blood. This can lead to symptoms such as fatigue, shortness of breath, and dizziness. Treatment for anemia may include medications such as erythropoietin or iron supplements, or treatments such as blood transfusions or dialysis.
Iron Deficiency Anemia:
Iron deficiency anemia is a condition wherein there is a lack of iron in the body. The most common symptom associated with this disease is fatigue, which may progress into other symptoms such as irritability, weakness, and shortness of breath.
Sickle Cell Anemia:
Sickle cell anemia is a blood disorder caused by abnormal hemoglobin, which is responsible for decreased red blood cells and increased RBCs (red blood cells) in the sickle cell disease (SCD) or the hereditary spherocytosis (HSS). The drug used for treatment of this condition varies according to different types of SCDs.
Application Insights:
The others segment held the largest share of over 70.0% in 2017. The application includes home healthcare and other external facilities such as research centers, blood banks and hemophilia treatment centers. Increasing awareness about anemia is one of the key factors driving its application in other external facilities over hospitals or clinics.
Iron deficiency accounted for a significant share in 2017 due to increasing prevalence globally coupled with high unmet medical needs due to low efficiency of iron absorption from dietary sources alone among others causes of anemia according to WHO statistics published last year (2017).
Regional Analysis:
North America dominated the global market in 2017. High prevalence of chronic diseases, such as cancer, diabetes, and arthritis is anticipated to drive the regional market over the forecast period. In addition, increasing R&D activities by major companies for development of new drugs is expected to fuel growth during the forecast period.
Asia Pacific region is anticipated to witness lucrative CAGR over the forecast period owing to rising healthcare expenditure and growing patient awareness regarding available treatment options. Moreover, availability of generic drugs due to low price competition among manufacturers will also support growth in near future.
Growth Factors:
- Increasing prevalence of anemia: The increasing prevalence of anemia is one of the key growth drivers for the anemia therapeutics market. According to a study by the World Health Organization (WHO), around 30% of the world’s population suffers from some form of anemia. This number is expected to increase in the coming years due to various factors such as rising population, malnutrition, and increasing incidence of diseases such as cancer and HIV/AIDS.
- Growing awareness about anemia: There is a growing awareness among people about anemia and its symptoms. This has led to a rise in demand for effective treatments for this condition.
- Technological advancements in hemoglobin testing: Hemoglobin testing technologies have undergone significant advancements in recent years, which has helped improve diagnosis rates for anemia cases. This is likely to boost demand for therapies targeting this condition over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Anemia Therapeutics Market Research Report
By Type
Iron Deficiency Anemia, Sickle Cell Anemia, Pernicious Anemia, Hemolytic Anemia
By Application
Hospitals, Clinics, Others
By Companies
Sanofi, Acceleron Pharma, Bayer, GlaxoSmithKline, Novartis, Pieris Pharmaceuticals, AMAG Pharmaceuticals, Daiichi Sankyo, Galenica, Pharmacosmos
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
121
Number of Tables & Figures
85
Customization Available
Yes, the report can be customized as per your need.
Global Anemia Therapeutics Market Report Segments:
The global Anemia Therapeutics market is segmented on the basis of:
Types
Iron Deficiency Anemia, Sickle Cell Anemia, Pernicious Anemia, Hemolytic Anemia
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Acceleron Pharma
- Bayer
- GlaxoSmithKline
- Novartis
- Pieris Pharmaceuticals
- AMAG Pharmaceuticals
- Daiichi Sankyo
- Galenica
- Pharmacosmos
Highlights of The Anemia Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Iron Deficiency Anemia
- Sickle Cell Anemia
- Pernicious Anemia
- Hemolytic Anemia
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anemia Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anemia Therapeutics is a biotechnology company focused on the development of novel therapeutics to address anemia. The company's lead product candidate, ANA-101, is a novel oral small molecule that targets iron deficiency anemia. ANA-101 has been shown to improve hemoglobin levels and reduce the need for blood transfusions in patients with iron deficiency anemia.
Some of the major players in the anemia therapeutics market are Sanofi, Acceleron Pharma, Bayer, GlaxoSmithKline, Novartis, Pieris Pharmaceuticals, AMAG Pharmaceuticals, Daiichi Sankyo, Galenica, Pharmacosmos.
The anemia therapeutics market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anemia Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anemia Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anemia Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anemia Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anemia Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Anemia Therapeutics Market Size and Y-o-Y Growth
4.5.2 Anemia Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Iron Deficiency Anemia
5.2.2 Sickle Cell Anemia
5.2.3 Pernicious Anemia
5.2.4 Hemolytic Anemia
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anemia Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anemia Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Iron Deficiency Anemia
9.6.2 Sickle Cell Anemia
9.6.3 Pernicious Anemia
9.6.4 Hemolytic Anemia
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Iron Deficiency Anemia
10.6.2 Sickle Cell Anemia
10.6.3 Pernicious Anemia
10.6.4 Hemolytic Anemia
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Iron Deficiency Anemia
11.6.2 Sickle Cell Anemia
11.6.3 Pernicious Anemia
11.6.4 Hemolytic Anemia
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Iron Deficiency Anemia
12.6.2 Sickle Cell Anemia
12.6.3 Pernicious Anemia
12.6.4 Hemolytic Anemia
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Iron Deficiency Anemia
13.6.2 Sickle Cell Anemia
13.6.3 Pernicious Anemia
13.6.4 Hemolytic Anemia
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anemia Therapeutics Market: Competitive Dashboard
14.2 Global Anemia Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Acceleron Pharma
14.3.3 Bayer
14.3.4 GlaxoSmithKline
14.3.5 Novartis
14.3.6 Pieris Pharmaceuticals
14.3.7 AMAG Pharmaceuticals
14.3.8 Daiichi Sankyo
14.3.9 Galenica
14.3.10 Pharmacosmos
